Zimmer Biomet Holdings Beheer
Beheer criteriumcontroles 3/4
De CEO Zimmer Biomet Holdings is Ivan Tornos, benoemd in Mar2021, heeft een ambtstermijn van 3.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 10.19M, bestaande uit 9.5% salaris en 90.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.013% van de aandelen van het bedrijf, ter waarde $ 2.92M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.7 jaar en 6.3 jaar.
Belangrijke informatie
Ivan Tornos
Algemeen directeur
US$10.2m
Totale compensatie
| Percentage CEO-salaris | 9.5% |
| Dienstverband CEO | 3.7yrs |
| Eigendom CEO | 0.01% |
| Management gemiddelde ambtstermijn | 3.7yrs |
| Gemiddelde ambtstermijn bestuur | 6.3yrs |
Recente managementupdates
Recent updates
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 02Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly
Aug 27Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | n/a | n/a | US$997m |
| Mar 31 2024 | n/a | n/a | US$964m |
| Dec 31 2023 | US$10m | US$969k | US$1b |
| Sep 30 2023 | n/a | n/a | US$474m |
| Jun 30 2023 | n/a | n/a | US$506m |
| Mar 31 2023 | n/a | n/a | US$450m |
| Dec 31 2022 | US$6m | US$823k | US$290m |
| Sep 30 2022 | n/a | n/a | US$366m |
| Jun 30 2022 | n/a | n/a | US$334m |
| Mar 31 2022 | n/a | n/a | US$325m |
| Dec 31 2021 | US$5m | US$731k | US$445m |
| Sep 30 2021 | n/a | n/a | US$834m |
| Jun 30 2021 | n/a | n/a | US$914m |
| Mar 31 2021 | n/a | n/a | US$563m |
| Dec 31 2020 | US$4m | US$730k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$152m |
| Jun 30 2020 | n/a | n/a | US$37m |
| Mar 31 2020 | n/a | n/a | US$377m |
| Dec 31 2019 | US$4m | US$700k | US$1b |
| Sep 30 2019 | n/a | n/a | -US$90m |
| Jun 30 2019 | n/a | n/a | -US$359m |
| Mar 31 2019 | n/a | n/a | -US$308m |
| Dec 31 2018 | US$4m | US$113k | -US$379m |
Compensatie versus markt: De totale vergoeding ($USD 10.19M ) Ivan } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.73M ).
Compensatie versus inkomsten: De vergoeding van Ivan is het afgelopen jaar met meer dan 20% gestegen.
CEO
Ivan Tornos (49 yo)
3.7yrs
Tenure
US$10,191,476
Compensatie
Mr. Ivan Tornos serves as Independent External Director at PHC Holdings Corporation since September 03, 2021. He joined PHC Holdings Corporation on September 03, 2021. Mr. Tornos serves as Chief Operating...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| COO, President | 3.7yrs | US$10.19m | 0.013% $ 2.9m | |
| CFO and Executive VP of Finance | 5.3yrs | US$10.38m | 0.015% $ 3.2m | |
| Senior VP | 17.5yrs | US$2.87m | 0.025% $ 5.4m | |
| President of Asia Pacific | 9.4yrs | US$3.38m | 0.0027% $ 580.7k | |
| Group President of Europe | 3.4yrs | US$3.42m | 0.0046% $ 1.0m | |
| VP, Controller & Chief Accounting Officer | 2.5yrs | geen gegevens | 0.00069% $ 150.1k | |
| Senior VP & Chief Information and Technology Officer | less than a year | geen gegevens | geen gegevens | |
| Senior VP & Chief Administrative Officer | less than a year | geen gegevens | 0.0034% $ 748.2k | |
| Senior VP of Investor Relations | less than a year | geen gegevens | geen gegevens | |
| Senior VP | 9.4yrs | geen gegevens | geen gegevens | |
| Senior VP & Chief Human Resources Officer | 3.8yrs | geen gegevens | 0.0017% $ 365.4k | |
| Senior Vice President of Global Quality & Regulatory Affairs | 7.3yrs | geen gegevens | geen gegevens |
3.7yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ZBH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| COO, President | 1.3yrs | US$10.19m | 0.013% $ 2.9m | |
| Independent Chairman of the Board | 12.3yrs | US$409.38k | 0.0018% $ 387.1k | |
| Independent Director | 15.8yrs | US$340.26k | 0.0027% $ 576.4k | |
| Independent Director | 16.7yrs | US$358.20k | 0.0020% $ 437.2k | |
| Independent Director | 17.8yrs | US$347.75k | 0.0017% $ 371.9k | |
| Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 6.3yrs | US$314.44k | 0.00083% $ 180.5k | |
| Independent Director | 9.9yrs | US$342.52k | 0.0010% $ 217.5k | |
| Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 3.8yrs | US$382.35k | 0.00050% $ 108.7k | |
| Independent Director | 6.3yrs | US$367.52k | 0.0020% $ 443.7k |
6.3yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ZBH wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.3 jaar).